Showing results (21-30 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|August 30, 2014
Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 - 2012Carmen Ferrajolo, Annalisa Capuano, Gianluca Trifirò, et al.Expert Opinion on Drug Safety|September 2, 2014
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluationYara Dadalti FragosoExpert Opinion on Drug Safety|November 23, 2012
Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticalsHugo M Vargas, Hamid R Amouzadeh, Michael J EngwallExpert Opinion on Drug Safety|March 23, 2013
Testosterone exposure in childhood: discerning pathology from physiologySusanne M Cabrera, Alan D RogolExpert Opinion on Drug Safety|December 25, 2015
Safety issues and adverse reactions with osteoporosis managementMaurizio Rossini, Giovanni Adami, Silvano Adami, et al.Expert Opinion on Drug Safety|January 15, 2016
Safety profiles of old and new antimicrobials for the treatment of MRSA infectionsMatteo Bassetti, Elda RighiExpert Opinion on Drug Safety|January 9, 2016
Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in ThailandNarumol Jarernsiripornkul, Pacharaporn Phueanpinit, Juraporn Pongwecharak, et al.Expert Opinion on Drug Safety|January 12, 2016
Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in ThailandArunrot Patsuree, Janet Krska, Narumol JarernsiripornkulExpert Opinion on Drug Safety|January 21, 2016
Long-term side effects of glucocorticoidsMerih Oray, Khawla Abu Samra, Nazanin Ebrahimiadib, et al.Expert Opinion on Drug Safety|January 23, 2016
Adverse events associated with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemiaMassimo Breccia, Gioia Colafigli, Matteo Molica, et al.Pageof 281